Nippon Shinyaku Co., Ltd.

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, IPSEY has a market cap of 57B. Regarding current trading prices, NPPNY is priced at $8.62, while IPSEY trades at $43.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas IPSEY's P/E ratio is 28.16. In terms of profitability, NPPNY's ROE is +0.12%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, NPPNY is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check IPSEY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, MKGAF has a market cap of 54.1B. Regarding current trading prices, NPPNY is priced at $8.62, while MKGAF trades at $124.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas MKGAF's P/E ratio is 15.96. In terms of profitability, NPPNY's ROE is +0.12%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, NPPNY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MKGAF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TKPHF has a market cap of 53.8B. Regarding current trading prices, NPPNY is priced at $8.62, while TKPHF trades at $34.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TKPHF's P/E ratio is 77.39. In terms of profitability, NPPNY's ROE is +0.12%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, NPPNY is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TKPHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, MKKGY has a market cap of 52.1B. Regarding current trading prices, NPPNY is priced at $8.62, while MKKGY trades at $23.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas MKKGY's P/E ratio is 15.37. In terms of profitability, NPPNY's ROE is +0.12%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, NPPNY is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MKKGY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HLNCF has a market cap of 42.8B. Regarding current trading prices, NPPNY is priced at $8.62, while HLNCF trades at $4.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HLNCF's P/E ratio is 19.24. In terms of profitability, NPPNY's ROE is +0.12%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, NPPNY is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HLNCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SDZNY has a market cap of 32.8B. Regarding current trading prices, NPPNY is priced at $8.62, while SDZNY trades at $75.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SDZNY's P/E ratio is 36.25. In terms of profitability, NPPNY's ROE is +0.12%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, NPPNY is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SDZNY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, NPPNY is priced at $8.62, while TEVJF trades at $28.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, NPPNY's ROE is +0.12%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, NPPNY and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SGIOF has a market cap of 18.3B. Regarding current trading prices, NPPNY is priced at $8.62, while SGIOF trades at $21.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SGIOF's P/E ratio is 17.02. In terms of profitability, NPPNY's ROE is +0.12%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, NPPNY and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, NPPNY is priced at $8.62, while TAIPY trades at $14.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, NPPNY's ROE is +0.12%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, NPPNY is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TAIPY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SGIOY has a market cap of 17.8B. Regarding current trading prices, NPPNY is priced at $8.62, while SGIOY trades at $10.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SGIOY's P/E ratio is 16.64. In terms of profitability, NPPNY's ROE is +0.12%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, NPPNY is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SGIOY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, NPPNY is priced at $8.62, while ESALY trades at $61.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ESALY's P/E ratio is 20.54. In terms of profitability, NPPNY's ROE is +0.12%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, NPPNY is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ESALY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, BIOVF has a market cap of 14.3B. Regarding current trading prices, NPPNY is priced at $8.62, while BIOVF trades at $41.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas BIOVF's P/E ratio is 295.14. In terms of profitability, NPPNY's ROE is +0.12%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, NPPNY and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, NPPNY is priced at $8.62, while IPSEF trades at $113.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, NPPNY's ROE is +0.12%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, NPPNY is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check IPSEF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ESAIY has a market cap of 8.6B. Regarding current trading prices, NPPNY is priced at $8.62, while ESAIY trades at $7.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ESAIY's P/E ratio is 28.07. In terms of profitability, NPPNY's ROE is +0.12%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, NPPNY is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ESAIY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ESALF has a market cap of 8.6B. Regarding current trading prices, NPPNY is priced at $8.62, while ESALF trades at $30.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ESALF's P/E ratio is 27.82. In terms of profitability, NPPNY's ROE is +0.12%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, NPPNY is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ESALF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SFOSF has a market cap of 6.5B. Regarding current trading prices, NPPNY is priced at $8.62, while SFOSF trades at $2.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SFOSF's P/E ratio is 13.53. In terms of profitability, NPPNY's ROE is +0.12%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, NPPNY is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SFOSF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, NPPNY is priced at $8.62, while LVZPF trades at $5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, NPPNY's ROE is +0.12%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, NPPNY is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check LVZPF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, NPPNY is priced at $8.62, while GZPHF trades at $2.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, NPPNY and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, DNPUF has a market cap of 5.3B. Regarding current trading prices, NPPNY is priced at $8.62, while DNPUF trades at $13.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas DNPUF's P/E ratio is 5.45. In terms of profitability, NPPNY's ROE is +0.12%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, NPPNY is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check DNPUF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SMDPY has a market cap of 4.8B. Regarding current trading prices, NPPNY is priced at $8.62, while SMDPY trades at $12.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SMDPY's P/E ratio is 4.95. In terms of profitability, NPPNY's ROE is +0.12%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, NPPNY is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SMDPY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, NPPNY is priced at $8.62, while HLUBF trades at $4.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HLUBF's P/E ratio is 9.84. In terms of profitability, NPPNY's ROE is +0.12%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, NPPNY is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HLUBF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, NPPNY is priced at $8.62, while HLBBF trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HLBBF's P/E ratio is 11.18. In terms of profitability, NPPNY's ROE is +0.12%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, NPPNY and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, NPPNY is priced at $8.62, while SGFEF trades at $100.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SGFEF's P/E ratio is 20.66. In terms of profitability, NPPNY's ROE is +0.12%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, NPPNY is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SGFEF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, NPPNY is priced at $8.62, while HKMPF trades at $17.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, NPPNY's ROE is +0.12%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, NPPNY is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HKMPF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, NPPNY is priced at $8.62, while APNHF trades at $8.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas APNHF's P/E ratio is -34.17. In terms of profitability, NPPNY's ROE is +0.12%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, NPPNY is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check APNHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HKMPY has a market cap of 3.6B. Regarding current trading prices, NPPNY is priced at $8.62, while HKMPY trades at $33.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HKMPY's P/E ratio is 9.13. In terms of profitability, NPPNY's ROE is +0.12%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, NPPNY is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HKMPY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, NPPNY is priced at $8.62, while ULIHF trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ULIHF's P/E ratio is 7.08. In terms of profitability, NPPNY's ROE is +0.12%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, NPPNY is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ULIHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, APNHY has a market cap of 3.3B. Regarding current trading prices, NPPNY is priced at $8.62, while APNHY trades at $7.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas APNHY's P/E ratio is -31.17. In terms of profitability, NPPNY's ROE is +0.12%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, NPPNY and APNHY have similar daily volatility (0.00).Check APNHY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, NPPNY is priced at $8.62, while LBTSF trades at $15.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, NPPNY's ROE is +0.12%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, NPPNY and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, NPPNY is priced at $8.62, while CHSYF trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, NPPNY's ROE is +0.12%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, NPPNY is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CHSYF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HYPMY has a market cap of 3.2B. Regarding current trading prices, NPPNY is priced at $8.62, while HYPMY trades at $4.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HYPMY's P/E ratio is 12.53. In terms of profitability, NPPNY's ROE is +0.12%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, NPPNY is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HYPMY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, NPPNY is priced at $8.62, while INVVY trades at $21.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas INVVY's P/E ratio is -62.42. In terms of profitability, NPPNY's ROE is +0.12%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, NPPNY and INVVY have similar daily volatility (0.00).Check INVVY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, NPPNY is priced at $8.62, while IZQVF trades at $20.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, NPPNY's ROE is +0.12%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, NPPNY and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, NPPNY is priced at $8.62, while HMDCF trades at $2.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, NPPNY's ROE is +0.12%, compared to HMDCF's ROE of +0.42%. Regarding short-term risk, NPPNY is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HMDCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, NPPNY is priced at $8.62, while NPNKF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas NPNKF's P/E ratio is 10.77. In terms of profitability, NPPNY's ROE is +0.12%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, NPPNY and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, NPPNY is priced at $8.62, while DMPHF trades at $39.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, NPPNY's ROE is +0.12%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, NPPNY is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check DMPHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, NPPNY is priced at $8.62, while HTSUF trades at $29.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, NPPNY's ROE is +0.12%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, NPPNY and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, NPPNY is priced at $8.62, while ARSUF trades at $27.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ARSUF's P/E ratio is 18.75. In terms of profitability, NPPNY's ROE is +0.12%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, NPPNY and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, NPPNY is priced at $8.62, while DUTV trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas DUTV's P/E ratio is N/A. In terms of profitability, NPPNY's ROE is +0.12%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, NPPNY is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check DUTV's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CURLF has a market cap of 1.8B. Regarding current trading prices, NPPNY is priced at $8.62, while CURLF trades at $2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CURLF's P/E ratio is -7.09. In terms of profitability, NPPNY's ROE is +0.12%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, NPPNY is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CURLF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, NPPNY is priced at $8.62, while TSMRF trades at $23.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, NPPNY's ROE is +0.12%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, NPPNY is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TSMRF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, NPPNY is priced at $8.62, while SHPHF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, NPPNY's ROE is +0.12%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, NPPNY and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, NPPNY is priced at $8.62, while MITPF trades at $23.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas MITPF's P/E ratio is -10.81. In terms of profitability, NPPNY's ROE is +0.12%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, NPPNY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MITPF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, NPPNY is priced at $8.62, while GTBIF trades at $6.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas GTBIF's P/E ratio is 13.67. In terms of profitability, NPPNY's ROE is +0.12%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, NPPNY is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GTBIF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, NPPNY is priced at $8.62, while KARBF trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas KARBF's P/E ratio is 262.50. In terms of profitability, NPPNY's ROE is +0.12%, compared to KARBF's ROE of N/A. Regarding short-term risk, NPPNY and KARBF have similar daily volatility (0.00).Check KARBF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, NPPNY is priced at $8.62, while CHIZF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, NPPNY's ROE is +0.12%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, NPPNY and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, NPPNY is priced at $8.62, while CASBF trades at $3.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CASBF's P/E ratio is -38.60. In terms of profitability, NPPNY's ROE is +0.12%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, NPPNY is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CASBF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, NPPNY is priced at $8.62, while SWGHF trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, NPPNY's ROE is +0.12%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, NPPNY and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, NPPNY is priced at $8.62, while TCNNF trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TCNNF's P/E ratio is -10.78. In terms of profitability, NPPNY's ROE is +0.12%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, NPPNY is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TCNNF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, NPPNY is priced at $8.62, while LJUIF trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, NPPNY's ROE is +0.12%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, NPPNY is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check LJUIF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, NPPNY is priced at $8.62, while BIOGY trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, NPPNY's ROE is +0.12%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, NPPNY and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, NPPNY is priced at $8.62, while KSPHF trades at $25.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, NPPNY's ROE is +0.12%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, NPPNY is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check KSPHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, NPPNY is priced at $8.62, while KKPCF trades at $26.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, NPPNY's ROE is +0.12%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, NPPNY is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check KKPCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, GNMLF has a market cap of 973.8M. Regarding current trading prices, NPPNY is priced at $8.62, while GNMLF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas GNMLF's P/E ratio is 11.11. In terms of profitability, NPPNY's ROE is +0.12%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, NPPNY is less volatile compared to GNMLF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GNMLF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, EVOTF has a market cap of 931.2M. Regarding current trading prices, NPPNY is priced at $8.62, while EVOTF trades at $5.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas EVOTF's P/E ratio is -5.04. In terms of profitability, NPPNY's ROE is +0.12%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, NPPNY is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check EVOTF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, NPPNY is priced at $8.62, while TWAPF trades at $16.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, NPPNY's ROE is +0.12%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, NPPNY is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TWAPF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, NPPNY is priced at $8.62, while NIKA trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas NIKA's P/E ratio is N/A. In terms of profitability, NPPNY's ROE is +0.12%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, NPPNY and NIKA have similar daily volatility (0.00).Check NIKA's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, NPPNY is priced at $8.62, while CSWYF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, NPPNY's ROE is +0.12%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, NPPNY is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CSWYF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, NPPNY is priced at $8.62, while TRXPF trades at $24.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, NPPNY's ROE is +0.12%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, NPPNY and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, NPPNY is priced at $8.62, while SHEZF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, NPPNY's ROE is +0.12%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, NPPNY is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SHEZF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, NPPNY is priced at $8.62, while YIHCF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, NPPNY and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, NPPNY is priced at $8.62, while AIHLF trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, NPPNY's ROE is +0.12%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, NPPNY and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, NPPNY is priced at $8.62, while TRSSF trades at $1.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, NPPNY's ROE is +0.12%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, NPPNY is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check TRSSF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, GLASF has a market cap of 582M. Regarding current trading prices, NPPNY is priced at $8.62, while GLASF trades at $7.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas GLASF's P/E ratio is -35.86. In terms of profitability, NPPNY's ROE is +0.12%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, NPPNY is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GLASF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, NPPNY is priced at $8.62, while PKBFF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas PKBFF's P/E ratio is N/A. In terms of profitability, NPPNY's ROE is +0.12%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, NPPNY and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, NPPNY is priced at $8.62, while CCHWF trades at $0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, NPPNY's ROE is +0.12%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, NPPNY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CCHWF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, NPPNY is priced at $8.62, while BOIRF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, NPPNY's ROE is +0.12%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, NPPNY and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, NPPNY is priced at $8.62, while AGYTF trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, NPPNY and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, KHTRF has a market cap of 498.1M. Regarding current trading prices, NPPNY is priced at $8.62, while KHTRF trades at $5.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas KHTRF's P/E ratio is -127.01. In terms of profitability, NPPNY's ROE is +0.12%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, NPPNY and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, NPPNY is priced at $8.62, while PEXXF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to PEXXF's ROE of N/A. Regarding short-term risk, NPPNY and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SWDCF has a market cap of 439.2M. Regarding current trading prices, NPPNY is priced at $8.62, while SWDCF trades at $2.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SWDCF's P/E ratio is 68.69. In terms of profitability, NPPNY's ROE is +0.12%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, NPPNY is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check SWDCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, VRNOF has a market cap of 434.2M. Regarding current trading prices, NPPNY is priced at $8.62, while VRNOF trades at $1.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas VRNOF's P/E ratio is -1.21. In terms of profitability, NPPNY's ROE is +0.12%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, NPPNY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check VRNOF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HUMDF has a market cap of 407.7M. Regarding current trading prices, NPPNY is priced at $8.62, while HUMDF trades at $0.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HUMDF's P/E ratio is 2.58. In terms of profitability, NPPNY's ROE is +0.12%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, NPPNY is less volatile compared to HUMDF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check HUMDF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ELTP has a market cap of 399.6M. Regarding current trading prices, NPPNY is priced at $8.62, while ELTP trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ELTP's P/E ratio is 9.28. In terms of profitability, NPPNY's ROE is +0.12%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, NPPNY is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ELTP's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CRLBF has a market cap of 340.8M. Regarding current trading prices, NPPNY is priced at $8.62, while CRLBF trades at $0.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CRLBF's P/E ratio is -2.61. In terms of profitability, NPPNY's ROE is +0.12%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, NPPNY is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CRLBF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CPHRF has a market cap of 305.5M. Regarding current trading prices, NPPNY is priced at $8.62, while CPHRF trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CPHRF's P/E ratio is 11.47. In terms of profitability, NPPNY's ROE is +0.12%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, NPPNY and CPHRF have similar daily volatility (0.00).Check CPHRF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, NPPNY is priced at $8.62, while BHCCF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, NPPNY's ROE is +0.12%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, NPPNY is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check BHCCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, NPPNY is priced at $8.62, while PLNHF trades at $0.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, NPPNY's ROE is +0.12%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, NPPNY is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check PLNHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, NPPNY is priced at $8.62, while PHCUF trades at $7.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, NPPNY is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check PHCUF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, NPPNY is priced at $8.62, while SHIEF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, NPPNY's ROE is +0.12%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, NPPNY and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, NPPNY is priced at $8.62, while COPHF trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas COPHF's P/E ratio is -0.02. In terms of profitability, NPPNY's ROE is +0.12%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, NPPNY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check COPHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CBWTF has a market cap of 130.8M. Regarding current trading prices, NPPNY is priced at $8.62, while CBWTF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CBWTF's P/E ratio is 3.23. In terms of profitability, NPPNY's ROE is +0.12%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, NPPNY is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CBWTF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, LOVFF has a market cap of 129.9M. Regarding current trading prices, NPPNY is priced at $8.62, while LOVFF trades at $1.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas LOVFF's P/E ratio is 15.07. In terms of profitability, NPPNY's ROE is +0.12%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, NPPNY is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check LOVFF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, NPPNY is priced at $8.62, while NWPN trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas NWPN's P/E ratio is -0.04. In terms of profitability, NPPNY's ROE is +0.12%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, NPPNY is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check NWPN's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, BIOYF has a market cap of 121.2M. Regarding current trading prices, NPPNY is priced at $8.62, while BIOYF trades at $10.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas BIOYF's P/E ratio is 19.20. In terms of profitability, NPPNY's ROE is +0.12%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, NPPNY is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check BIOYF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, NPPNY is priced at $8.62, while LPCUF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, NPPNY's ROE is +0.12%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, NPPNY is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check LPCUF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CWBHF has a market cap of 110M. Regarding current trading prices, NPPNY is priced at $8.62, while CWBHF trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CWBHF's P/E ratio is -4.93. In terms of profitability, NPPNY's ROE is +0.12%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, NPPNY is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check CWBHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, NPPNY is priced at $8.62, while CNVCF trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, NPPNY and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, AAWH has a market cap of 101.3M. Regarding current trading prices, NPPNY is priced at $8.62, while AAWH trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas AAWH's P/E ratio is -0.86. In terms of profitability, NPPNY's ROE is +0.12%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, NPPNY is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check AAWH's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, NPPNY is priced at $8.62, while ORXOY trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ORXOY's P/E ratio is -2.26. In terms of profitability, NPPNY's ROE is +0.12%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, NPPNY and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, NPPNY is priced at $8.62, while ABSCF trades at $1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, NPPNY's ROE is +0.12%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, NPPNY is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ABSCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, HLTRF has a market cap of 93.8M. Regarding current trading prices, NPPNY is priced at $8.62, while HLTRF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas HLTRF's P/E ratio is -7.69. In terms of profitability, NPPNY's ROE is +0.12%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, NPPNY and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, JUSHF has a market cap of 90.8M. Regarding current trading prices, NPPNY is priced at $8.62, while JUSHF trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas JUSHF's P/E ratio is -1.40. In terms of profitability, NPPNY's ROE is +0.12%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, NPPNY is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check JUSHF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, ORXOF has a market cap of 79.3M. Regarding current trading prices, NPPNY is priced at $8.62, while ORXOF trades at $2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas ORXOF's P/E ratio is -1.84. In terms of profitability, NPPNY's ROE is +0.12%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, NPPNY is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check ORXOF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, GRUSF has a market cap of 77.4M. Regarding current trading prices, NPPNY is priced at $8.62, while GRUSF trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas GRUSF's P/E ratio is 10.33. In terms of profitability, NPPNY's ROE is +0.12%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, NPPNY is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check GRUSF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, PROCF has a market cap of 75M. Regarding current trading prices, NPPNY is priced at $8.62, while PROCF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas PROCF's P/E ratio is 0.08. In terms of profitability, NPPNY's ROE is +0.12%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, NPPNY and PROCF have similar daily volatility (0.00).Check PROCF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, MEDXF has a market cap of 74.3M. Regarding current trading prices, NPPNY is priced at $8.62, while MEDXF trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas MEDXF's P/E ratio is -115.00. In terms of profitability, NPPNY's ROE is +0.12%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, NPPNY is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for NPPNY.Check MEDXF's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, NPPNY is priced at $8.62, while EOFBY trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, NPPNY's ROE is +0.12%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, NPPNY and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here

NPPNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPPNY stands at 2.3B. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, NPPNY is priced at $8.62, while GDNSF trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPPNY currently has a P/E ratio of 11.65, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, NPPNY's ROE is +0.12%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, NPPNY and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here